Project purpose
Digi 2.0 was created after the project Digi 1.0 concluded that building a common digital data sharing platform that integrates data from different and multiple sources is critical to achieve greater transparency to the pharma supply chain stakeholders.
Project objective(s)
Project Digi 2.0 aims to develop the Proof of Concept into a Prototype, the Global Pharma Tracker (GPT), by incorporating data from real shipments for a selected trade lane and expanding the platform capabilities.
Project status and key-takeaways
This project was finalized in December 2019.
Digi 2.0 was divided into 4 work packages:
- Work Package 1: Technical implementation
- Work Package 2: Pilot onboarding
- Work Package 3: Business Value drivers
- Work Package 4: System Validation
The GPT was presented and demonstrated to the Pharma.Aero User Board and key departments in major pharmaceuticals shippers such as Pfizer, MSD and Johnson & Johnson, which acknowledged that the GPT is a value-adding tool to their supply chain management.
Shipment data (e.g. milestones and activity duration, temperature events etc.) made available in a data warehouse format allows shippers to perform analysis. With AI and machine learning, more fine-grained predictive and prescriptive decision-making on a trade lane could be achieved.
Read more details in the White Paper.
Project support and collaboration
- Project leads: Brussels Airport Company, Changi Airport Group, Pfizer
- Project members: Mumbai Airport, Singapore Airlines, DHL Global Forwarding, AirBridgeCargo, Amerijet, EuroAirport, Hong Kong International Airport, Johnson & Johnson, Kansai International Airport, MSD, MVD Free Airport (now LACC), Sharjah Airport
- Project external support: Brussels Airlines, Nallian
- Project manager and expert: Hilde Havermans, Frank Van Gelder (external consultants)